Twenty-one weeks into her pregnancy, Barbara Farlow discovered that her daughter Annie would be born with the genetic disorder trisomy 13, a chromosomal abnormality — and a label — that would ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Oxford Gene Technology (OGT) and the Wellcome Trust Sanger Institute are pleased to announce the signing of a collaboration agreement to develop a single platform microarray to test for genetic ...

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Chromosomal Microarray Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...

The surge in genomics and proteomics research for disease diagnosis, drug discovery, and personalized medicine is a primary driver of the DNA microarray market. Applications in Disease Diagnostics: ...

Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Global Microarray Analysis Market - A Global and Regional Analysis: Focus on Product, Type, Application, End User, Region, Country Level Analysis and ...

Genome sequencing is a comprehensive genetic test that is being integrated into health care systems internationally. Test indications include suspected genetic disorders in children and adults for ...

NEW YORK, March 25, 2024--(BUSINESS WIRE)--Nucleus Genomics, the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of ...

Reportlinker.com announces that a new market research report is available in its catalogue: Microarray Marketshttp://www.reportlinker.com/p096372/Microarray-Markets ...

As genetic analysis expands to serve everything from population-scale studies to precision-driven clinical decisions, laboratories are under growing pressure to move faster while managing increasingly ...